Author & Principal Investigator
Pedro Martinez-Clark, MD, FACC
CEO and Principal Investigator, Amavita Research — Harvard-trained interventional cardiologist leading cardiovascular clinical trials in Miami.
Role at Amavita Research
CEO and Principal Investigator
Dr. Martinez-Clark leads Amavita Research as Chief Executive Officer and serves as Principal Investigator on cardiovascular clinical trials conducted at the site in North Miami Beach, Florida. He is responsible for protocol oversight, investigator decisions, and the medical care of participants enrolled at Amavita Research.
Biography
Dr. Pedro Martinez-Clark began his medical career in Colombia before moving to the United States for advanced training. He completed research at Harvard, his medical residency at Case Western Reserve University, and returned to Harvard for specialized training in cardiovascular and interventional cardiology.
He later joined the University of Miami as a professor and physician, working alongside renowned cardiologist Dr. William O'Neill on complex structural-heart cases. Dr. Martinez-Clark has led more than 25 clinical research trials and contributed to the development of the Trans-Caval approach to transcatheter aortic valve replacement.
He is a Fellow of the American College of Cardiology (FACC) and recipient of the 2023 Apogee Award for Excellence in Healthcare. In 2017 he founded amavita Heart and Vascular Health®, where he serves as CEO. The clinic works with Jackson Memorial and Mercy Hospitals while remaining independent to keep patients first.
Areas of Focus
- Cardiovascular & interventional cardiology
- Cardiac catheterization
- Coronary revascularization
- Heart valve repair & replacement
- Venous ablation
- Peripheral artery disease treatments
Training
- Research at Harvard
- Medical residency, Case Western Reserve University
- Cardiovascular & interventional cardiology training, Harvard
Recognition
- Fellow, American College of Cardiology (FACC)
- 2023 Apogee Award for Excellence in Healthcare
- QM-IAOCR — Internationally Qualified Clinical Research Investigator